AMRN did trade down significantly just on the press release dated Sept 12 that BDA posted. I understand exactly what they said in reference to TL being released before the end of Sept but the Twitterverse went crazy with posts that results were going to be delayed, blah, blah, blah. I think the price went from approx $3.10 to $2.90 so my description as a large sell off may be overstated.

Here is my exact post on another board.

"

Msg  2853 of 4886  at  9/12/2018 12:20:30 PM  by

KillerNut

edit  |   delete

In response to msg 2852 by  ex_hacker202	view thread

Re: R-IT primary results to be presented at Nov. AHA conference

Is the sell off today because folks think V topline results are delayed? I dont see it. Doubled my already large position."

 

 

 

----------------

 

Also in response to the poster thinking there is a lack of interest, THERE CERTAINLY IS A LACK OF INTEREST.

RVX is running so far under the radar. I follow quite a few wide ranging Biotech message boards and various posts

are made from time to time listing upcoming catalysts in the sector. RVX IS NEVER MENTIONED.

 

That is one reason I really like the reward/risk here and RVX is my largest position.